Contrasting Biotricity (NASDAQ:BTCY) & Alpha Tau Medical (NASDAQ:DRTS)

Biotricity (NASDAQ:BTCY) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk and institutional ownership.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Biotricity and Alpha Tau Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biotricity	0	1	0	0	2.00
Alpha Tau Medical	0	0	3	0	3.00

Alpha Tau Medical has a consensus price target of $8.00, indicating a potential upside of 243.35%. Given Alpha Tau Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Alpha Tau Medical is more favorable than Biotricity.

Profitability

This table compares Biotricity and Alpha Tau Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Biotricity	-117.42%	N/A	-242.92%
Alpha Tau Medical	N/A	-33.75%	-26.78%

Volatility & Risk

Biotricity has a beta of 1.33, suggesting that its share price is 33% more volatile than the S&P 500. Comparatively, Alpha Tau Medical has a beta of 0.77, suggesting that its share price is 23% less volatile than the S&P 500.

Institutional and Insider Ownership

3.9% of Biotricity shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 10.0% of Biotricity shares are owned by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares Biotricity and Alpha Tau Medical”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotricity	$12.06 million	0.84	-$14.09 million	($1.32)	-0.34
Alpha Tau Medical	N/A	N/A	-$29.16 million	($0.41)	-5.68

Biotricity has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Biotricity, indicating that it is currently the more affordable of the two stocks.

Summary

Alpha Tau Medical beats Biotricity on 7 of the 13 factors compared between the two stocks.

About Biotricity

Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

About Alpha Tau Medical

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.